Salvatore Delogu - Concepedia

Author

Salvatore Delogu

University of California, San Francisco

Also Known As

Salvatore Delogu

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

University of California, San Francisco University of Chieti-Pescara Universität Greifswald Universitätsmedizin Greifswald University Hospital Heidelberg

About

Salvatore Delogu is an author at University of California, San Francisco specializing in cancer research, cell signaling, and liver physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	1.1K
2	Cell Biology	4	4	1.1K
3	Health Sciences	2	2	152
4	Hepatology	2	2	714
5	Pathology	2	2	953

Salvatore Delogu

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Increased Lipogenesis, Induced by AKT-mTORC1-RPS6 Signaling, Promotes Development of Human Hepatocellular Carcinoma Diego F. Calvisi, Chunmei Wang, Coral Ho, Gastroenterology Tumor BiologyHepatologyHuman Hepatocellular CarcinomaMedicineLiver Physiology	2010	621
Yes-Associated Protein Up-regulates Jagged-1 and Activates the NOTCH Pathway in Human Hepatocellular Carcinoma Darjus F. Tschaharganeh, Xin Chen, Philipp Latzko, Gastroenterology Signaling PathwayHuman Hepatocellular CarcinomaMedicineLiver PhysiologyYes-associated Protein	2013	332
AKT (v-akt murine thymoma viral oncogene homolog 1) and N-Ras (neuroblastoma ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)/SKP2, and c-Myc pathways Coral Ho, Chunmei Wang, Sandra Mattu, Hepatology	2011	230
Functional crosstalk between AKT/mTOR and Ras/MAPK pathways in hepatocarcinogenesis: Implications for the treatment of human liver cancer Chunmei Wang, Antonio Cigliano, Salvatore Delogu, Cell Cycle Mtorc1 Inhibitor RapamycinRas/mapk PathwaysCancer BiologyTumor BiologyHcc Development	2013	93
V-AKT murine thymoma viral oncogene homolog/mammalian target of rapamycin activation induces a module of metabolic changes contributing to growth in insulin-induced hepatocarcinogenesis Matthias Evert, Diego F. Calvisi, Katja Evert, Hepatology	2012	60
Inactivation of Spry2 accelerates AKT-driven hepatocarcinogenesis via activation of MAPK and PKM2 pathways Chunmei Wang, Salvatore Delogu, Coral Ho, Journal of Hepatology Cancer ResearchSignal TransductionMedicineLiver PhysiologyReceptor Tyrosine Kinase	2012	59
SKP2 cooperates with N-Ras or AKT to induce liver tumor development in mice Salvatore Delogu, Chunmei Wang, Antonio Cigliano, Oncotarget	2014	31

Page 1